Weedstock - Cannabis Market Intelligence | Stock Tracker & News

Real-time cannabis stock tracking, expert market analysis, and breaking marijuana industry news.

Home

⭐ Top Story

📈 Top Movers

📰 Today's News

🌿

From the Village Green

Daily curated intelligence from social media — cannabis market trends, breaking news, regulatory updates & M&A signals

Daily Cannabis Industry Intelligence

Curated from social media posts and threads

Published: Saturday, May 2, 2026 | 7:00 AM ET | Curated by Sheeba

Curaleaf Completes Full Acquisition of Four 20 Pharma

Curaleaf Holdings (TSX: CURA) completed its buyout of the remaining 45% stake in Four 20 Pharma, a leading EU-GMP licensed German medical cannabis producer. The deal strengthens Curaleaf’s vertically integrated supply chain. Read more →

Vireo Growth Acquires FLUENT in Florida Consolidation Deal

Vireo Growth (CNSX: VREO) entered a definitive agreement to acquire Florida-based FLUENT Corp. in an all-stock transaction. Combined entity will operate ~74 retail stores and 144,000 sq ft cultivation. Q4 2026 close. Read more →

Trulieve Files DEA Schedule III Medical Registration

Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) filed DEA applications for Schedule III registration of 200+ medical dispensaries. Under expedited pathway, licensure deemed approved unless DEA objects within 60 days. Read more →

Verano Holdings Reports Strong Q1 2026 Revenue

Verano Holdings announced robust first-quarter 2026 results with $208M revenue, continuing growth trajectory as leading multi-state operator. Read more →

Aurora Cannabis Acquires Safari Flower Company

Aurora Cannabis (NASDAQ: ACB, TSX: ACB) acquired Safari Flower’s 59,000 sq ft EU-GMP facility in Ontario for $26.5M. Expansion supports Germany, Australia, Poland, UK markets. Read more →

DEA Schedule III Registration Creates Compliance Catch-22

Industry attorneys flag critical issue: DEA forms require operators to acknowledge activity resembling federal trafficking. Experts pressing for form revisions before deadline—potential barrier to compliance. Read more →

Cannabis-Derived Pharma Companies Revive IPO Plans

Pharmaceutical companies developing cannabis therapeutics reviving IPO plans post-rescheduling. Bankers anticipate uptick in cannabis-pharma deal flow as barriers lower, reshaping valuations. Read more →

Splash-Medterra CBD Merger Agreement

Splash Beverage Group (NYSE: SBEV) executed non-binding LOI with Medterra CBD. Combined entity as cannabinoid wellness platform serving 2M+ customers, pursuing CMS CBD pilot reimbursement. Read more →

Fette Pharma Exits Restructuring

Fette Pharma, German medical cannabis distributor, formally exited restructuring. Move clears regulatory overhangs, positions for accelerated competition in Europe’s largest medical market. Read more →

Cannabis ETFs Return to Institutional Radars

Cannabis-focused ETFs back on institutional radars with positive flows post-rescheduling. Asset remains volatile but liquidity and engagement clearly returning. Read more →

Conflicting Federal Guidance Muddles Benefits

Week post-rescheduling, conflicting federal signals cloud operator clarity on banking, taxation, interstate movement. Disorderly rollout risks blunting commercial upside priced into Schedule III decision. Read more →

M&A Wave Accelerates: European Consolidation Leads

Industry consolidation accelerates globally with European medical cannabis transactions leading. Organigram’s Sanity Group acquisition signals operators moving now to capture market advantages. Read more →

About Village Green: Curated daily cannabis industry intelligence. Sourced from Twitter/X, Reddit, LinkedIn, industry publications.

Next update: Sunday, May 3, 2026 | 7:00 AM ET

📅 Yesterday's News & Older Articles →